Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pharmacology
  4. Activation of α6-containing GABAA receptors induces antinociception under physiological and pathological conditions

Activation of α6-containing GABAA receptors induces antinociception under physiological and pathological conditions

Pain, 2023 · DOI: 10.1097/j.pain.0000000000002763 · Published: May 1, 2023

PharmacologyNeurologyPain Management

Simple Explanation

This study investigates the role of α6-containing GABAA receptors in pain, particularly neuropathic pain, in rats and mice. Neuropathic pain is often associated with a decrease in GABAergic inhibition. The study aims to see if activating these receptors can reduce neuropathic pain. The researchers found that blocking or reducing the activity of these receptors in female rats caused increased sensitivity to pain. Conversely, activating these receptors reduced pain in neuropathic female rats and mice. The α6 subunit is found in specific nerve cells in the spinal cord and DRG. The study also found that nerve injury reduces the expression of the α6 subunit, and that the effects of activating these receptors were more pronounced in females than in males. The α6 subunit is also expressed in human spinal cord.

Study Duration
Not specified
Participants
Female and male Wistar rats and Swiss webster mice
Evidence Level
Not specified

Key Findings

  • 1
    α6-containing GABAA receptor blockade or knockdown induces hypersensitivity and spontaneous pain in naïve female rats.
  • 2
    Nerve injury reduces α6 subunit protein expression in the central terminals of primary afferent neurons and DRG.
  • 3
    PAMs of the α6-containing GABAA receptor reduces tactile allodynia and spontaneous nociceptive behaviors in female, but not male, neuropathic rats and mice.

Research Summary

This study investigated the role of α6-containing GABAA receptors in physiological conditions and neuropathic pain using rats and mice. The study found that α6-containing GABAA receptor blockade or knockdown induces hypersensitivity and spontaneous pain in naïve female rats. The study also revealed that nerve injury reduces α6 subunit protein expression in the central terminals of the primary afferent neurons and DRG. Furthermore, PAMs of the α6-containing GABAA receptor reduces tactile allodynia and spontaneous nociceptive behaviors in female, but not male, neuropathic rats and mice. The researchers found that the antiallodynic effect of the α6-containing GABAA receptor is greater in female than in male rodents. Finally, this receptor is expressed in the human spinal cord, suggesting it could be a target for neuropathic pain treatment.

Practical Implications

Potential Therapeutic Target

The α6-containing GABAA receptor could represent a novel target for developing treatments for neuropathic pain.

Sex-Specific Treatment Strategies

The sex-specific antinociceptive role of the α6-containing GABAA receptor suggests that treatment strategies should consider sex differences.

Restoration of GABAergic Inhibition

Restoring GABAergic inhibition via α6-containing GABAA receptor activation might be a viable approach for managing neuropathic pain.

Study Limitations

  • 1
    The study primarily uses animal models, and the translational relevance to human neuropathic pain requires further investigation.
  • 2
    The precise mechanisms underlying the sex-dependent effects of α6-containing GABAA receptors in neuropathic pain remain unclear.
  • 3
    Non-viral vectors induce transient expression and low gene delivery to cells

Your Feedback

Was this summary helpful?

Back to Pharmacology